This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

The World Market For Stents (Drug-Eluting And Bare Metal Product Markets In US, EU, Japan, India, China And ROW)

Abbott Laboratories

  • Biosensors International
  • Boston Scientific
  • Biotronik SE & Co.KG
  • CID Vascular
  • Elixir Medical Corporation
  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Medical ( Shanghai) Co., Ltd Minvasys
  • OrbusNeich
  • REVA Medical
  • Stentys S.A.
  • Terumo Corporation

CHAPTER ONE: EXECUTIVE SUMMARY

Disease Overview

Cardiovascular Disease

Market Overview

Revenue Forecast

CHAPTER TWO: CARDIOVASCULAR DISEASE OVERVIEW

Disease Overview

Top Ten Causes of Death

World Cardiovascular Disease Statistics

Mortality Rates for IHD

Economic Burden of Cardiovascular Disease

Expenditure on Cardiovascular Disease, Worldwide

Prevalence of Ischemic Heart Disease

CHAPTER THREE: CORONARY STENTS OVERVIEW

Overview

Restenosis

 

Types of Stents

Bare Metal Stents

First Generation of Bare Metal Stents

 

Second Generation of Bare Metal Stents

 

Third Generation of Bare Metal Stents

 

Omega Platinum-Chromium Stent

 

Nuloy Molybdenum-Rhenium Stent

 

 

Safety Issues of Bare Metal Stents

 

 

Drug-Eluting Stents

Types of Drugs Used on Drug-Eluting Stents

Paclitaxel

 

Sirolimus

 

Everolimus

 

Tacrolimus

 

Biolimus A9

 

Novolimus

 

Other Drug Classes

 

 

Types of Polymers

Safety Concerns of Drug-Eluting Stents

 

Late Stent Thrombosis

 

Mechanical Problems of Polymers

 

 

 

CHAPTER FOUR: RECENT ADVANCES IN CORONARY STENTS TECHNOLOGIES

 

Reduced Polymer Coatings

Biodegradable Polymers

Advantages and Disadvantages of Biodegradable Polymers

 

Current Biodegradable Polymers Stents

 

BioMatrix

 

Nobori

 

Supralimus

 

Infinnium

 

DESyne BD stent

 

Synergy

 

MiStent

 

BioMime

 

Abrax

 

 

Polymer-Free and Novel Coatings Drug-eluting Stents

Optima Jet

 

Cre8

 

Orsiro Hybrid DES

 

EPC Capturing Technology

 

 

Direct Application of Drug on Stent Surface

Amazonia Pax

 

Yukon DES

 

BioFreedom

 

Mitsu

 

Medtronic S10 platform

 

Catania stent

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,869.47 -266.25 -1.47%
S&P 500 2,074.69 -26.35 -1.25%
NASDAQ 4,933.3860 -49.4230 -0.99%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs